ABVX · Abivax S.A.
$114.39
-2.14 (-1.83%)
At close · Aug 27
Market Cap
$10.17B
Shares
87.25M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$116.52
Open$117.00
Day$116.01–118.00
52W close$72.50–145.31
Avg vol 30d917K
Short int6.0M · 6.9% float · 7.8d
Short vol54%
Last earningsDec 31, 2023
DataOct 2023–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−2%
below
Price vs 50-day avg
−5%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
60%
mid-range
Momentum
relative strength
1-month return
−2%
trailing
6-month return
+3%
trailing
YTD return
−14%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $123 › 200d $119 — 50d above 200d
Institutional flow
Accumulating
+21% holders QoQ · +95 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.88% of float · ▲ +15.5% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
307 holders — near 2-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
85%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−2%
Neutral
Price vs 50-day avg
−5%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
60%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $123 › 200d $119 — 50d above 200d
Institutional flow
Accumulating
+21% holders QoQ · +95 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.88% of float · ▲ +15.5% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
307 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $73
Now $117 · 60%
Range high $145
vs 200-day avg -2%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABVX
this stock
Abivax S.A.
|
$10.17B | -13.6% | — | — | 6.9% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.72B | +20.7% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +5.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$65.12B | +24.5% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.92B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABVX | -3.4% | -2.0% | +3.4% | -6.7% | -13.6% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | -3.0% | -7.0% | -9.1% | -9.3% | -25.9% |
Key facts
CIK
1956827
CUSIP
00370M103
13F (30d)
266 filings
266 filers
Visit website
Investor relations